Unraveling the mystery of Alzheimer’s resilience at molecular level

FHS
May 16, 2024
5:19 pm

Everyone experiences aging in their own way, and factors such as genetics, lifestyle and environment play a role in this process.

TORL scores $158m in Series B2 to advance ADC cancer therapies

Share this article TORL plans to use the funds to finance multiple ongoing Phase I trials. Image Credit: Olivier Le Moal / Shutterstock. TORL BioTherapeutics

April 10, 2024

USC receives $2 million grant to advance cell and gene therapy research

The Keck School of Medicine of USC has received $2 million from the California Institute of Regenerative Medicine (CIRM) to further augment its newly launched

October 5, 2023

Bavarian Nordic seeks authorisation for mpox vaccine’s use in adolescents – Pharmaceutical Technology

Bavarian Nordic’s mpox vaccine is currently only indicated for adults 18 years and older. Image credit: Shutterstock/ Riccardo Mayer. Amid the ongoing global mpox public

August 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.